Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$232.35 -5.93 (-2.49%)
At close: Sep 29, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Current Debt (2011)

Updated

Jazz Pharmaceuticals' Current Debt was -$7.35 million in FY2011, compared with -$2.05 million in FY2010.

Analysis

Jazz Pharmaceuticals (JAZZ) Current Debt (2011) Analysis & Trends

  • Per Business Quant data, Current Debt in earlier years was -$2.05 million in FY2010 and $5.52 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Jazz Pharmaceuticals 15.47 Bn 9.29 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 -4.00 Mn
Mar 31, 2011 -3.35 Mn
API Access

Jazz Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=JAZZ&period=max&api_key=YOUR_API_KEY